Pillstats
Rx only · Liquid · Oral

Glycopyrrolate

Brands: Cuvposa · Glycopyrrolate

2 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US2 NDCs
2 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCD11AA01
RxCUI (US)1546438
US makers2 labelers
Packages2
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 2 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.181$0.361$0.542$0.722Dec 2025Apr 2026Jul 2026
$0.600
Latest avg · Jul 22, 2026
-3%
Since Dec 17, 2025
2
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

6791.4K2.0K2.7K2025 Q12025 Q22025 Q32025 Q42026 Q1
1.6K
Rx · 2026 Q1
672K
Units dispensed
-20%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it2 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Novadoz Pharmaceuticals LLCunknown1SUPPLYING
Merz Pharmaceuticals, LLCunknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Dec 15, 2025
    RECALLRecall (Class III): Glycopyrrolate Oral Solution, 1 mg/5 mL, 16 oz. (473 mL), Rx only, Manufactured by: MSN Pharmaceuticals Inc., Piscatawa…

    Failed Impurities/Degradation Specifications — Recalling firm: NOVADOZ PHARMACEUTICALS LLC — US Nationwide.